3 hours LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of “Buy” by Brokerages MarketBeat
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a b…